Literature DB >> 33597290

Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease.

Katharine Huynh1, Olivier Piguet1, John Kwok1, Carol Dobson-Stone1, Glenda M Halliday1, John R Hodges1, Ramón Landin-Romero2.   

Abstract

OBJECTIVE: To test the hypothesis that white matter hyperintensities (WMH) in behavioral-variant frontotemporal dementia (bvFTD) and Alzheimer disease (AD) are associated with disease variables such as disease severity, cortical atrophy, and cognition, we conducted a cross-sectional brain MRI study with volumetric and voxel-wise analyses.
METHODS: A total of 129 patients (64 bvFTD, 65 AD) and 66 controls underwent high-resolution brain MRI and clinical and neuropsychological examination. Genetic screening was conducted in 124 cases (54 bvFTD, 44 AD, 26 controls) and postmortem pathology was available in 18 cases (13 bvFTD, 5 AD). WMH were extracted using an automated segmentation algorithm and analyses of total volumes and spatial distribution were conducted. Group differences in total WMH volume and associations with vascular risk and disease severity were examined. Syndrome-specific voxel-wise associations between WMH, cortical atrophy, and performance across different cognitive domains were assessed.
RESULTS: Total WMH volumes were larger in patients with bvFTD than patients with AD and controls. In bvFTD, WMH volumes were associated with disease severity but not vascular risk. Patients with bvFTD and patients with AD showed distinct spatial patterns of WMH that mirrored characteristic patterns of cortical atrophy. Regional WMH load correlated with worse cognitive performance in discrete cognitive domains. WMH-related cognitive impairments were shared between syndromes, with additional associations found in bvFTD.
CONCLUSION: Increased WMH are common in patients with bvFTD and patients with AD. Our findings suggest that WMH are partly independent of vascular pathology and associated with the neurodegenerative process. WMH occur in processes independent of and related to cortical atrophy. Furthermore, increased WMH in different regions contributes to cognitive deficits.
© 2021 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33597290     DOI: 10.1212/WNL.0000000000011638

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Association Between Antemortem FLAIR White Matter Hyperintensities and Neuropathology in Brain Donors Exposed to Repetitive Head Impacts.

Authors:  Madeline Uretsky; Sylvain Bouix; Ronald J Killiany; Yorghos Tripodis; Brett Martin; Joseph Palmisano; Asim Z Mian; Karen Buch; Chad Farris; Daniel H Daneshvar; Brigid Dwyer; Lee Goldstein; Douglas Katz; Christopher Nowinski; Robert Cantu; Neil Kowall; Bertrand Russell Huber; Robert A Stern; Victor E Alvarez; Thor D Stein; Ann McKee; Jesse Mez; Michael L Alosco
Journal:  Neurology       Date:  2021-11-24       Impact factor: 9.910

2.  Medial Temporal Atrophy Contributes to Cognitive Impairment in Cerebral Small Vessel Disease.

Authors:  Wenshan Sun; Lili Huang; Yue Cheng; Ruomeng Qin; Hengheng Xu; Pengfei Shao; Junyi Ma; Zhelv Yao; Lin Shi; Yun Xu
Journal:  Front Neurol       Date:  2022-05-18       Impact factor: 4.086

3.  Enlarged perivascular spaces and white matter hyperintensities in patients with frontotemporal lobar degeneration syndromes.

Authors:  Ming-Liang Wang; Zheng Sun; Wen-Bin Li; Qiao-Qiao Zou; Peng-Yang Li; Xue Wu; Yue-Hua Li
Journal:  Front Aging Neurosci       Date:  2022-07-28       Impact factor: 5.702

4.  White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Philippe Desmarais; Andrew F Gao; Julia Keith; Mario Masellis; Krista Lanctôt; Ekaterina Rogaeva; Joel Ramirez; Nathan Herrmann; Donald T Stuss; Sandra E Black
Journal:  Alzheimers Res Ther       Date:  2021-07-13       Impact factor: 6.982

5.  White matter hyperintensity topography in Alzheimer's disease and links to cognition.

Authors:  Antoine Garnier-Crussard; Salma Bougacha; Miranka Wirth; Sophie Dautricourt; Siya Sherif; Brigitte Landeau; Julie Gonneaud; Robin De Flores; Vincent de la Sayette; Denis Vivien; Pierre Krolak-Salmon; Gaël Chételat
Journal:  Alzheimers Dement       Date:  2021-07-28       Impact factor: 16.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.